PharmaShots | Incisive News in 3 Shots

Subscribe Now

F508del

Vertex Pharmaceuticals' Orkambi (lumacaftor+ivacaftor) Receives EU Approval for Cystic Fibrosis (CF) with Mutation in CFTR gene in Children Aged 2 to 5

Vertex Pharmaceuticals' Orkambi (lumacaftor+ivacaftor) Receives EU Approval for Cystic Fibrosis (CF) with Mutation in CFTR gene in...

January 21, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us